At 8.8% CAGR, the global Transcranial Magnetic Stimulator (TMS) market is estimated to accumulate US$ 2,029.71 million by 2028, says The Insight Partners

 Transcranial Magnetic Stimulator (TMS) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Single or Paired Pulse TMS, Repetitive TMS (rTMS)); Age Group (Adults, Children); Application (Research, Diagnostic, Therapeutic), and Geography

Repetitive TMS (rTMS) Segment to Lead Transcranial Magnetic Stimulator (TMS) Market During 2021–2028

 

According to our latest study on “Transcranial Magnetic Stimulator (TMS) Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Age Group, and Application,” the market is projected to reach US$ 2,029.71 million by 2028 from US$ 1,122.22 million in 2021; it is expected to register a CAGR of 8.8% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

           

Based on type, the transcranial magnetic stimulator (TMS) market is segmented single or paired pulse TMS and repetitive TMS (rTMS). In 2021, the single or paired pulse TMS segment held a larger share of the market. However, the repetitive TMS (rTMS) segment is expected to witness a higher CAGR during the forecast period.

 

BrainsWay Ltd; Nexstim; Magstim; Neuronetics; TMS Neuro Solutions; MagVenture, Inc.; eNeura Inc.; Neurosoft; MAG & More GmbH are among the leading companies operating in the transcranial magnetic stimulator (TMS) market.

 

The transcranial magnetic stimulator (TMS) market is segmented into type, age group, and application. Based on type, the market is segmented into single or paired pulse TMS and repetitive TMS (rTMS). Based on age group, the market is segmented into adults and children. Based on application, the market is segmented into diagnostic, therapeutic, and research.

 

Geographically, the transcranial magnetic stimulator (TMS) market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and Rest of APAC), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM).

Comments

Post a Comment

Popular posts from this blog

Automatic Checkweigher Market is estimated to accumulate US$ 342.4 Mn by 2027, says The Insight Partners

  Automatic Checkweigher Market  to 2027 - Global Analysis and Forecasts By Type (Standalone Systems, Combination Systems); Technology (Strain Gauge, Electro Magnetic Force Restoration (EMFR)); End-user Industry (Food and Beverages, Pharmaceuticals, Consumer Products, Cosmetics and Personal Care, Others) The global automatic checkweigher market accounted for US$ 235.2 Mn in 2018 and is expected to grow at a CAGR of 4.6% over the forecast period 2019–2027, to account for US$ 342.4 Mn by 2027.   The checkweighers made up of stainless steel components can withstand harsh conditions and repeated contact with water.  Other materials can be painted with the materials that can impart resistance to damages, but these will not hold up to unrelenting or washdown environments. Most of the load cells are made of aluminum.  These operate well and cost less than stainless steel load cells, but they are not designed to handle contact with water or other corrosives. They ...
Read more

Pancreatic Cancer Therapy Market Size, Growth, Analysis by Recent Trends, Development and Forecast To 2025

  Rise in number of patients suffering with pancreatic cancer is driving the market for pancreatic cancer therapy over the forecast period According to The Insight Partners market research study titled ‘Pancreatic Cancer Therapy Market - Global Analysis and Forecasts By Type, Therapy, the global pancreatic cancer therapy market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025. The report highlights the trends prevalent in the global pancreatic cancer therapy market and the factors driving the market along with those that act as deterrents to its growth. Global pancreatic cancer therapy market, based on the type was segmented into endocrine pancreatic cancer and exocrine pancreatic cancer. In 2017, the exocrine pancreatic cancer segment held the largest share of the market, by type. The exocrine pancreatic cancer segment is expected to grow at the fastest rate during the coming years as t...
Read more